Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com
Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock. Tonix Pharmaceuticals Stock Performance Shares of Tonix Pharmaceuticals stock opened at $11.94 on Monday. The company’s 50 day moving average price […]
